A 91-year-old woman with difficult-to-control hypertension: A clinical review

JAMA

Volumn 310, Issue 12, 2013, Pages 1274-1280

  Lipsitz, Lewis A ^a,b,c  

^a Hebrew Senior Life   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CHLORTALIDONE; CLONIDINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOSARTAN; METHYLDOPA; NEBIVOLOL; PLACEBO; PRAZOSIN; SPIRONOLACTONE; TERAZOSIN; THIAZIDE DIURETIC AGENT;

AGED; ARTERIAL STIFFNESS; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR MORTALITY; CLINICAL STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DAILY LIFE ACTIVITY; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; FUNCTIONAL DISEASE; GERIATRIC PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOTENSION; MENTAL DETERIORATION; MORBIDITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; URINARY FREQUENCY; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE;

EID: 84884649413     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.277027     Document Type: Review

References (40)

1. Lloyd-Jones D, Adams R, Carnethon M, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2009 update. Circulation. 2009;119(3):e21-e181.
2. Denardo SJ, Gong Y, Nichols WW, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med. 2010;123(8):719-726.
3. Dorresteijn JA, van der Graaf Y, Spiering W, Grobbee DE, Bots ML, Visseren FL; Secondary Manifestations of Arterial Disease Study Group. Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited. Hypertension. 2012;59(1):14-21.
4. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
5. Kannel WB, D'Agostino RB, Silbershatz H. Blood pressure and cardiovascular morbidity and mortality rates in the elderly. Am Heart J. 1997;134(4):758-763. (Pubitemid 27465073)
6. Aronow WS, Fleg JL, Pepine CJ, et al; ACCF Task Force. ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Circulation. 2011;123(21):2434-2506.
7. Frohlich ED. Recommendations for blood pressure determination by sphygmomanometry. Ann Intern Med. 1988;109(8):612.
8. Jonsson PV, Lipsitz LA, Kelley M, Koestner J. Hypotensive responses to common daily activities in institutionalized elderly: a potential risk for recurrent falls. Arch Intern Med. 1990;150(7):1518-1524. (Pubitemid 20215695)
9. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: ameta-analysis of individual data for 1million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913. (Pubitemid 35472129)
10. Hajjar I, Quach L, Yang F, et al. Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the Cardiovascular Health Study. Circulation. 2011;123(8):858-865.
11. Tzourio C, Dufouil C, Ducimetière P, Alpérovitch A; EVA Study Group. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly: Epidemiology of Vascular Aging. Neurology. 1999;53(9):1948-1952.
12. Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med. 2012;172(15):1162-1168.
13. Sabayan B, van Vliet P, de Ruijter W, Gussekloo J, de Craen AJ, Westendorp RG. High blood pressure, physical and cognitive function, and risk of stroke in the oldest old: the Leiden 85-Plus Study. Stroke. 2013;44(1):15-20.
14. Guo Z, Viitanen M, Winblad B. Low blood pressure and five-year mortality in a Stockholm cohort of the very old: possible confounding by cognitive impairment and other factors. Am J Public Health. 1997;87(4):623-628. (Pubitemid 27208750)
15. Langer RD, Ganiats TG, Barrett-Connor E. Factors associated with paradoxical survival at higher blood pressures in the very old. Am J Epidemiol. 1991;134(1):29-38.
16. Mattila K, Haavisto M, Rajala S, Heikinheimo R. Blood pressure and five year survival in the very old. Br Med J (Clin Res Ed). 1988;296(6626):887-889. (Pubitemid 18081872)
17. Rastas SPT, Pirttilä T, Viramo P, et al. Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc. 2006;54(6):912-918. (Pubitemid 43847027)
18. Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304(1):61-68.
19. Lipsitz LA. Altered blood pressure homeostasis in advanced age: clinical and research implications. J Gerontol. 1989;44(6):M179-M183. (Pubitemid 19282256)
20. Masuo K, Mikami H, Ogihara T, Tuck ML. Changes in frequency of orthostatic hypotension in elderly hypertensive patients under medications. Am J Hypertens. 1996;9(3):263-268. (Pubitemid 26121277)
21. Lipsitz LA, Gagnon M, Vyas M, et al. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005;45(2):216-221. (Pubitemid 40179963)
22. O'Malley K, McCormack P, O'Brien ET. Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly. J Hypertens Suppl. 1988;6(1):S105-S108. (Pubitemid 19043908)
23. Coope JR, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed). 1987;294(6565):179. (Pubitemid 17223875)
24. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients With Hypertension (STOP-Hypertension). Lancet. 1991;338(8778):1281-1285.
25. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304(6824):405-412.
26. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24):3255-3264.
27. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program, II: mortality by race-sex and age. JAMA. 1979;242(23):2572-2577.
28. Staessen JA, Fagard R, Thijs L, et al; Systolic Hypertension in Europe Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350(9080):757-764.
29. Wang JG, Staessen JA, Gong L, Liu L; Systolic Hypertension in China Collaborative Group. Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med. 2000;160(2):211-220. (Pubitemid 30054341)
30. Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-1898. (Pubitemid 351620109)
31. Peters R, Beckett N, Forette F, et al; HYVET Investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7(8):683-689.
32. Ogihara T, Saruta T, Rakugi H, et al; Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly. Hypertension. 2010;56(2):196-202.
33. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31(12):2115-2127.
34. Whelton PK, Appel LJ, Espeland MA, et al; TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA. 1998;279(11):839-846. (Pubitemid 28185548)
35. Peterzan MA, Hardy R, Chaturvedi N, Hughes AD.Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension. 2012;59(6):1104-1109.
36. Kaplan NM. Chlorthalidone versus hydrochlorothiazide: a tale of tortoises and a hare. Hypertension. 2011;58(6):994-995.
37. Wing LM, Reid CM, Ryan P, et al; Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348(7):583-592.
38. Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417-2428.
39. Dahlöf B, Devereux RB, Kjeldsen SE, et al; LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. (Pubitemid 34286536)
40. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. JAMA. 2000;283(15):1967-1975.